Therapeutic Advances in Infectious Disease

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Therapeutic Advances in Infectious Disease is an open-access journal published by SAGE Publishing in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,800 USD. Declared review time at DOAJ: 9 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
2049-9361 · 2049-937X
Country
United States
Languages
english
Access
Open access
Declared publication charge
2,800 USD
Articles in DOAJ
576
Declared review time
9 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2019-06-10
Indexing
DOAJ
APC
2,800 USD
Declared review time (DOAJ)
9 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

576

Most recent article

last month

Average review time (journal-declared via DOAJ)

9weeks

Works in OpenAlex

619

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

44

i10-index

205

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-11-20
Added to DOAJ
2019-06-10
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
97%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101606715
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Infectious and parasitic diseases

LCC codes

RC109-216

Subject areas

  • Antifungal resistance and susceptibility
  • Antifungal resistance and susceptibility
  • HIV/AIDS Research and Interventions
  • HIV/AIDS Research and Interventions
  • Fungal Infections and Studies
  • Fungal Infections and Studies
  • Antibiotic Use and Resistance
  • Antibiotic Use and Resistance
Show all subjects (50)
  • Tuberculosis Research and Epidemiology
  • Tuberculosis Research and Epidemiology
  • COVID-19 Clinical Research Studies
  • HIV/AIDS drug development and treatment
  • COVID-19 Clinical Research Studies
  • Bacterial Identification and Susceptibility Testing
  • Bacterial Identification and Susceptibility Testing
  • HIV/AIDS drug development and treatment
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotics Pharmacokinetics and Efficacy
  • Antimicrobial Resistance in Staphylococcus
  • Antimicrobial Resistance in Staphylococcus
  • Pneumonia and Respiratory Infections
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV, Drug Use, Sexual Risk
  • Pneumonia and Respiratory Infections
  • HIV, Drug Use, Sexual Risk
  • Urinary Tract Infections Management
  • Urinary Tract Infections Management
  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Infective Endocarditis Diagnosis and Management
  • Parasites and Host Interactions
  • Infective Endocarditis Diagnosis and Management
  • Parasites and Host Interactions
  • Diagnosis and treatment of tuberculosis
  • Diagnosis and treatment of tuberculosis
  • SARS-CoV-2 and COVID-19 Research
  • Streptococcal Infections and Treatments
  • Streptococcal Infections and Treatments
  • SARS-CoV-2 and COVID-19 Research
  • HIV-related health complications and treatments
  • HIV-related health complications and treatments
  • Respiratory viral infections research
  • Nail Diseases and Treatments
  • Nail Diseases and Treatments
  • Clostridium difficile and Clostridium perfringens research
  • Neonatal and Maternal Infections
  • Infectious Diseases and Tuberculosis
  • HIV Research and Treatment
  • Hepatitis C virus research

Keywords (DOAJ)

  • infectious diseases
  • infection control
  • infection prevention

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: